High-dose topotecan (90 and 180 μG) for recurrent subretinal and vitreous seeding in retinoblastoma is a research paper published in American Journal of Ophthalmology Case Reports (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health National Cancer Institute
Grant: P30 CA009748
NCI NIH HHS
Grant: P30 CA008748
National Institutes of Health
Keywords